Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd., commonly referred to as Xiuzheng Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in Jilin City, China. Established in 1998, the company has made significant strides in the development and production of traditional Chinese medicine and modern pharmaceuticals, catering to both domestic and international markets. With a diverse portfolio that includes herbal medicines, chemical drugs, and health supplements, Xiuzheng Pharmaceutical stands out for its commitment to quality and innovation. The company has achieved notable milestones, including various certifications and recognitions that underscore its market position. As a leader in the pharmaceutical sector, Xiuzheng continues to expand its operational footprint, contributing to advancements in healthcare and wellness solutions.
How does Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd.'s score of 20 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd., headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. Given the absence of emissions data and reduction initiatives, it is unclear how Jilin Xiuzheng Pharmaceutical Group aligns with industry standards for climate action. The pharmaceutical sector is increasingly focusing on sustainability and carbon neutrality, and companies are encouraged to adopt science-based targets to mitigate their environmental impact. However, without specific commitments or data, it is challenging to assess the company's position within this context.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

